Nuzenio

Latigo

Latigo news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 24 latest news signals 12 publisher sources 100/100 entity strength

Latest news

Latigo Biotherapeutics, Inc (LTGO) Stock Price, News & Analyst Forecast - eToroeToro · Sat, 08 Aug 2026 10:51:51 GMT Latigo Biotherapeutics Prices $345.6 Million IPO - MoomooMoomoo · Fri, 07 Aug 2026 21:59:50 GMT Latigo Biotherapeutics, Clinical-Stage Developer of Selective Nav1.8 Non‑Opioid Pain Medicines for Acute and Chronic Pain, Files for Nasdaq Global Select Market IPO - TradingViewTradingView · Fri, 07 Aug 2026 20:39:00 GMT Latham & Watkins Advises on Latigo Biotherapeutics’ Upsized US$345.6 Million Initial Public Offering - Latham & Watkins LLPLatham & Watkins LLP · Fri, 07 Aug 2026 20:34:02 GMT biopharmaceutical company Latigo Biotherapeutics completes IPO - News Freedom Broker - Freedom BrokerFreedom Broker · Fri, 07 Aug 2026 20:33:23 GMT Latigo, BlossomHill cap busy week in biotech IPOs with nearly $500M haul - FirstWord PharmaFirstWord Pharma · Fri, 07 Aug 2026 17:52:10 GMT Pain drug developer Latigo rises post-upsized IPO (LTGO:NASDAQ) - Seeking AlphaSeeking Alpha · Fri, 07 Aug 2026 16:27:44 GMT BlossomHill, Latigo outshine IPO expectations with oversubscribed debuts - Fierce BiotechFierce Biotech · Fri, 07 Aug 2026 15:10:10 GMT

Timeline

Sat, 08 Aug 2026 10:51:51 GMTLatigo Biotherapeutics, Inc (LTGO) Stock Price, News & Analyst Forecast - eToro

Fri, 07 Aug 2026 21:59:50 GMTLatigo Biotherapeutics Prices $345.6 Million IPO - Moomoo

Fri, 07 Aug 2026 20:39:00 GMTLatigo Biotherapeutics, Clinical-Stage Developer of Selective Nav1.8 Non‑Opioid Pain Medicines for Acute and Chronic Pain, Files for Nasdaq Global Select Market IPO - TradingView

Fri, 07 Aug 2026 20:34:02 GMTLatham & Watkins Advises on Latigo Biotherapeutics’ Upsized US$345.6 Million Initial Public Offering - Latham & Watkins LLP

Fri, 07 Aug 2026 20:33:23 GMTbiopharmaceutical company Latigo Biotherapeutics completes IPO - News Freedom Broker - Freedom Broker

Fri, 07 Aug 2026 17:52:10 GMTLatigo, BlossomHill cap busy week in biotech IPOs with nearly $500M haul - FirstWord Pharma

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

NASDAQ18 live mentions LTGO17 live mentions Latigo Biotherapeutics Inc16 live mentions Latigo Biotherapeutics12 live mentions IPO9 live mentions LTGO TradingView TradingView8 live mentions Inc6 live mentions Yahoo Finance Singapore4 live mentions Offering3 live mentions BlossomHill3 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Latigo.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

12 distinct publisher/source names are currently connected to this entity page.